Gregory L Weaver is Former EVP, CFO, & Director of Atossa Therapeutics Inc.
Person profile
Roles
Atossa Therapeutics
Former EVP, CFO, & Director
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ATOSSA THERAPEUTICS, INC.
17 Nov 23
4
ATOSSA THERAPEUTICS, INC.
20 Jun 23
4
ATOSSA THERAPEUTICS, INC.
5 Jun 23
4
ATOSSA THERAPEUTICS, INC.
5 May 23
4
ATOSSA THERAPEUTICS, INC.
16 May 22
4
ATAI Life Sciences N.V.
4 Mar 22
4
ATOSSA THERAPEUTICS, INC.
7 Jul 21
4
ATAI Life Sciences N.V.
24 Jun 21
4
ATAI Life Sciences N.V.
22 Jun 21
3
ATAI Life Sciences B.V.
17 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Nov 23 | ATOS Atossa Therapeutics | Common Stock | Sell | Dispose S | No | No | 0.65 | 50,000 | 32.50 k | 55 |
20 Jun 23 | ATOS Atossa Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.97 | 50,000 | 48.50 k | 50,055 |
1 Jun 23 | ATOS Atossa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.92 | 2,600,000 | 2.39 mm | 2,600,000 |
4 May 23 | ATOS Atossa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.662 | 125,000 | 82.75 k | 125,000 |